Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 07, 2016 8:09 AM ET


Company Overview of Oriel Therapeutics, Inc.

Executive Profile

Paul J. Atkins Ph.D.

Co-Founder, President, Chief Operating Officer and Director, Oriel Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships


Dr. Paul J. Atkins, Ph.D., co-founded Oriel Therapeutics, Inc. in 2002 and serves as its Chief Operating Officer. Dr. Atkins served as Chief Executive Officer and President of Oriel Therapeutics, Inc. He was involved with the development and commercialization of inhaled delivery systems for GlaxoSmithKline. He served as Director, Delivery Systems in the Global Respiratory Therapeutic Development group of GlaxoSmithKline. With over 20 years in the pharmaceutical industry ...

Corporate Headquarters

630 Davis Drive
Morrisville, North Carolina 27713

United States

Phone: 919-313-1290
Fax: 919-313-1295

Board Members Memberships

Co-Founder, President, Chief Operating Officer and Director


University Of London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oriel Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at